Galectin Therapeutics (GALT) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

GALT is expected to report earnings to fall 15.00% to -17 cents per share on November 11

Galectin Therapeutics GALT Stock Earnings Reports

Q3'24

Est.

$-0.17

Q2'24

Missed

by $0.04

Q1'24

Missed

by $0.03

Q4'23

Missed

by $0.06

Q3'23

Missed

by $0.14

The last earnings report on August 13 showed earnings per share of -20 cents, missing the estimate of -15 cents. With 63.92K shares outstanding, the current market capitalization sits at 168.77M.

View a ticker or compare two or three

Compare

GALT

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For GALT
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of drugs to combat various diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

4960 Peachtree Industrial Boulevard

Phone

+1 678 620-3186

Employees

Web

https://www.galectintherapeutics.com